Nucleolin on the cell surface as a new molecular target for gastric cancer treatment
- PMID: 20460757
- DOI: 10.1248/bpb.33.796
Nucleolin on the cell surface as a new molecular target for gastric cancer treatment
Abstract
Nucleolin is an abundant non-ribosomal protein found in nucleolus and a major component of silver-stained nucleolar organizer region (AgNOR), a histopathological marker of cancer which is highly elevated in cancer cells. We recently reported that nucleolin on the cell surface of mouse gastric cancer cells acts as a receptor for tumor necrosis factor-alpha-inducing protein (Tipalpha), a new carcinogenic factor of Helicobacter pylori. In this study, we first examined the localization of nucleolin on cell surface of five gastric cancer cell lines by cell fractionation and flow cytometry: We found that large amounts of nucleolin were present on surface of MKN-45, KATOIII, MKN-74, and AGS cells, with smaller amounts on surface of MKN-1 cells. The membrane fraction of normal epithelial cells of mouse glandular stomach did not contain much nucleolin, suggesting that translocation of nucleolin to the cell surface occurs during carcinogenesis, making for easier binding with Tipalpha. AS1411, a nucleolin targeted DNA aptamer, inhibited growth of gastric cancer cell lines in this order of potency: MKN-45>KATOIII>AGS>MKN-74=MKN-1, associated with induction of S-phase cell cycle arrest. Fluorescein isothiocyanate (FITC)-AS1411 was more rapidly incorporated into MKN-45 and AGS than into MKN-1 cells, based on varying amounts of cell surface nucleolin. We think that AS1411 first binds to nucleolin on the cell surface and that the binding complex is then incorporated into the cells. All results indicate that nucleolin on the cell surface is a new and promising therapeutic target for treatment of gastric cancer.
Similar articles
-
Nucleolin as cell surface receptor for tumor necrosis factor-alpha inducing protein: a carcinogenic factor of Helicobacter pylori.J Cancer Res Clin Oncol. 2010 Jun;136(6):911-21. doi: 10.1007/s00432-009-0733-y. Epub 2010 Jan 5. J Cancer Res Clin Oncol. 2010. PMID: 20049476
-
Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-α-inducing protein of Helicobacter pylori.Int J Cancer. 2014 May 15;134(10):2373-82. doi: 10.1002/ijc.28582. Epub 2013 Nov 19. Int J Cancer. 2014. PMID: 24249671
-
Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.J Cancer Res Clin Oncol. 2014 May;140(5):689-99. doi: 10.1007/s00432-014-1587-5. Epub 2014 Jan 28. J Cancer Res Clin Oncol. 2014. PMID: 24469254 Free PMC article.
-
Role of TNF-α-Inducing Protein Secreted by Helicobacter pylori as a Tumor Promoter in Gastric Cancer and Emerging Preventive Strategies.Toxins (Basel). 2021 Mar 1;13(3):181. doi: 10.3390/toxins13030181. Toxins (Basel). 2021. PMID: 33804551 Free PMC article. Review.
-
Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori.Cancer Lett. 2012 Sep 28;322(2):133-8. doi: 10.1016/j.canlet.2012.03.027. Epub 2012 Mar 27. Cancer Lett. 2012. PMID: 22459353 Review.
Cited by
-
Prevalence of tumor necrosis factor alpha inducing protein (tipα) gene of Helicobacter pylori and its association with upper gastrointestinal diseases in India.3 Biotech. 2021 May;11(5):246. doi: 10.1007/s13205-021-02804-w. Epub 2021 Apr 30. 3 Biotech. 2021. PMID: 33968589 Free PMC article.
-
Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells.Surgery. 2011 Aug;150(2):224-30. doi: 10.1016/j.surg.2011.05.015. Surgery. 2011. PMID: 21801960 Free PMC article.
-
Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer.Cells. 2020 Apr 23;9(4):1055. doi: 10.3390/cells9041055. Cells. 2020. PMID: 32340207 Free PMC article. Review.
-
Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data.Biomolecules. 2022 May 11;12(5):691. doi: 10.3390/biom12050691. Biomolecules. 2022. PMID: 35625618 Free PMC article. Review.
-
Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer.Cancers (Basel). 2022 Apr 29;14(9):2217. doi: 10.3390/cancers14092217. Cancers (Basel). 2022. PMID: 35565346 Free PMC article.
